Impact of product originality and supply chain structure on market share in the pharmaceutical industry

dc.authorscopusid57193872823
dc.contributor.authorGöllü,E.
dc.date.accessioned2024-05-25T12:32:25Z
dc.date.available2024-05-25T12:32:25Z
dc.date.issued2017
dc.departmentOkan Universityen_US
dc.department-tempGöllü E., Department of Business Administration, Okan University, Istanbul, Turkeyen_US
dc.description.abstractPurpose: The purpose of this paper is to investigate the impact of supply chain structure on market share and the differences between supply chain structures and market shares of companies in terms of product originality in the pharmaceutical industry. Design/methodology/approach: In the design of this research, survey methodology was selected to collect the data. Convenience sampling technique and, as data collection instrument, a questionnaire including dichotomous scales were utilized. Findings: Obtained results showed that supply chain structures of pharmaceutical companies in Turkey have a significant impact on their market shares. Other results indicate that there are significant differences between both supply chain structures and market shares in terms of product originality. Research limitations/implications: There are three limitations, namely, the study focused on only one sector, convenience sampling method was used in conjunction with Pareto approach and the study encompasses Turkey only. Practical implications: Practitioners will benefit from this study through conceptualizing the impact of supply chain structure on market share and the relationships between these both and product originality in terms of creating competitive advantage. Originality/value: The importance of this study lies on the investigation of supply chain structure with its impact on market share from supply chain management perspective and on the combination of the relationships between these both constructs and product originality as from management perspective in the pharmaceutical industry as first time. © 2017, © Emerald Publishing Limited.en_US
dc.identifier.citation3
dc.identifier.doi10.1108/IJPHM-01-2016-0009
dc.identifier.endpage79en_US
dc.identifier.issn1750-6123
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-85017222387
dc.identifier.scopusqualityQ3
dc.identifier.startpage60en_US
dc.identifier.urihttps://doi.org/10.1108/IJPHM-01-2016-0009
dc.identifier.urihttps://hdl.handle.net/20.500.14517/2384
dc.identifier.volume11en_US
dc.language.isoen
dc.publisherEmerald Group Publishing Ltd.en_US
dc.relation.ispartofInternational Journal of Pharmaceutical and Healthcare Marketingen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMarket shareen_US
dc.subjectPharmaceutical industryen_US
dc.subjectProduct originalityen_US
dc.subjectSupply chain structureen_US
dc.subjectTurkeyen_US
dc.titleImpact of product originality and supply chain structure on market share in the pharmaceutical industryen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files